EXANE DERIVATIVES: GOLF position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on GOLF, newest first. How the timeline and the estimate are built.
EXANE DERIVATIVES held 0 GOLF shares at 2022-06-30 per its 13F-HR filed 2022-07-12.
the latest 13F is the newest step
- period ended2022-06-3013F 0 sharesChange vs previous 13F -2,743 shares
13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2022-03-3113F 2,743 sharesChange vs previous 13F -557 shares
0.03% of the 13F portfolio, value $110,426.
13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2021-12-3113F 3,300 sharesChange vs previous 13F -975 shares
0.04% of the 13F portfolio, value $175,158.
13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2021-09-3013F 4,275 sharesChange vs previous 13F -707 shares
0.05% of the 13F portfolio, value $199,635.
13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2021-06-3013F 4,982 sharesChange vs previous 13F +4,982 shares
0.06% of the 13F portfolio, value $250,190.
13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2021-03-3113F 0 sharesChange vs previous 13F -9,371 shares
13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2020-12-3113F 9,371 sharesChange vs previous 13F not available
0.12% of the 13F portfolio, value $379,883.
13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).